Application of Multiomics Approach to Investigate the Therapeutic Potentials of Stem Cell-derived Extracellular Vesicle Subpopulations for Alzheimer's Disease

Morteza Abyadeh,Alaattin Kaya

DOI: https://doi.org/10.1101/2024.05.10.593647

2024-05-14

Abstract:Alzheimer's disease (AD) presents a complex interplay of molecular alterations, yet understanding its pathogenesis remains a challenge. In this study, we delved into the intricate landscape of proteome and transcriptome changes in AD brains compared to healthy controls, examining 788 brain samples revealing common alterations at both protein and mRNA levels. Moreover, our analysis revealed distinct protein-level changes in aberrant energy metabolism pathways in AD brains that were not evident at the mRNA level. This suggests that the changes in protein expression could provide a deeper molecular representation of AD pathogenesis. Subsequently, using a comparative proteomic approach, we explored the therapeutic potential of mesenchymal stem cell-derived extracellular vehicles (EVs), isolated through various methods, in mitigating AD-associated changes at protein level. Our analysis revealed particular EV-subtype that can be utilized for compensating dysregulated mitochondrial proteostasis in AD brain. By using network biology approaches, we further revealed the potential regulators of key therapeutic proteins. Overall, our study illuminates the significance of proteome alterations in AD pathogenesis and identifies the therapeutic promise of a specific EV subpopulation with reduced pro-inflammatory protein cargo and enriched proteins to target mitochondrial proteostasis.

Genetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the complex molecular changes in Alzheimer's disease (AD) and its therapeutic potential. Specifically, through a multi - omics approach, that is, by combining transcriptomics and proteomics data, the study explored the potential value of subpopulations of stem - cell - derived extracellular vesicles (EVs) in the treatment of AD. The study mainly focused on the following points:

1. **Differences in proteome and transcriptome between AD brain tissue and healthy controls**:
- The study analyzed 788 brain samples and revealed common changes at the protein and mRNA levels between AD brain tissue and healthy controls.
- It was found that there were significant changes in the energy metabolism pathway at the protein level in AD brain tissue, while these changes were not obvious at the mRNA level. This indicates that changes in protein expression may more deeply reflect the pathological mechanism of AD.

2. **Therapeutic potential of different EV subpopulations**:
- By comparing EV subpopulations obtained by different isolation methods (including high - speed centrifugation (HS - EVs), ultra - centrifugation (UC - EVs) and sucrose - gradient centrifugation (SU - EVs)), the study explored their potential in alleviating AD - related protein changes.
- In particular, an EV subtype was discovered that can be used to compensate for the dysregulated mitochondrial protein homeostasis in AD brains and reduce the inflammatory response.

3. **In - depth understanding of the molecular mechanism**:
- Through network biology methods, the potential regulators of key therapeutic proteins were further revealed.
- The overall study shows that proteomic changes are of great significance in the pathological mechanism of AD and identifies the potential value of specific EV subpopulations in the treatment of AD, especially those EV subtypes rich in mitochondrial proteins and with a reduced content of pro - inflammatory proteins.

In conclusion, this paper aims to systematically analyze the molecular changes in AD brain tissue through a multi - omics approach and explore the potential application of stem - cell - derived EV subpopulations in the treatment of AD.